Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Urobilinogen is a biochemical compound that results from the reduction of bilirubin, a substance produced during the breakdown of red blood cells. This reduction process primarily occurs in the intestine, where bilirubin is converted into urobilinogen. A small portion of urobilinogen is then reabsorbed from the intestine into the bloodstream and subsequently filtered by the kidneys, which is part of the enterohepatic urobilinogen cycle. The measurement of urobilinogen in urine is significant as it can provide insights into various hepatic and hematological conditions. Elevated levels of urobilinogen in urine may indicate several medical issues, including biliary obstruction, hepatic infections, poisoning, or inflammation, as well as hemolytic anemia. Additionally, elevated levels can occur in cases where there is a large hematoma that the body is in the process of absorbing. Conversely, decreased levels of urobilinogen may be observed in conditions such as congenital enzymatic jaundice or when urine acidifying drugs are present. For qualitative evaluation of urobilinogen, the CPT® code 84578 is utilized, while 84580 is designated for quantitative, timed specimen evaluations, and 84583 is used for semiquantitative evaluations.
© Copyright 2026 Coding Ahead. All rights reserved.
Urobilinogen testing is indicated for the evaluation of various conditions that may affect liver function or red blood cell breakdown. The following are specific indications for performing this test:
The procedure for testing urobilinogen in urine involves the following steps:
After the urobilinogen testing procedure, the urine sample is typically discarded, and no special post-procedure care is required for the patient. However, it is important for healthcare providers to communicate the results to the patient and discuss any necessary follow-up actions based on the findings. If elevated or decreased levels of urobilinogen are detected, further diagnostic testing or clinical evaluation may be warranted to determine the underlying cause and appropriate management.
| Short Descr | TEST URINE UROBILINOGEN | Medium Descr | ASSAY OF UROBILINOGEN URINE QUALITATIVE | Long Descr | Urobilinogen, urine; qualitative | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-01 | Changed | Medium Descriptor changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.